Skip to content
“The pandemic has exposed our country’s dependence on other countries for essential prescription drugs,” began Steve Scully, contributing editor at The Hill and moderator […]
COVID-19 forced us to reimagine the pharma supply chain – and that’s a good thing Read More »
The U.S. was solely responsible for 61% of medicines approved by the U.S. Food and Drug Administration (FDA) between 2011-2020, says a new report
55% of FDA-approved drugs were developed by U.S. small biotechs, says study Read More »
This is a tough winter for respiratory disease. Coming off of a two-year pandemic we are finding that flu season now has a few
Fight the ‘tripledemic’ with vaccines, tests, and treatment Read More »
Paying for healthcare in the United States has been a challenging and controversial issue for years. In a landscape managed by private insurers, Medicaid,
To ensure access for all, healthcare payment models need innovation Read More »
Provisions in the Inflation Reduction Act (IRA) make it easier for people covered by Medicare Part D to pay for medicine, but continued government
CMS must flesh out plan to ease out-of-pocket drug costs, report says Read More »
Rachel King was enjoying her retirement. When the COVID-19 pandemic hit, King found herself with a chance to refocus and ask herself what was
Meet Rachel King, BIO’s new interim CEO and a champion of the biotech industry Read More »
What did we learn on Day 1 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit in Washington, D.C.? It’s all about
What we learned on Day 1 of the Patient and Health Advocacy Summit Read More »
The U.S. biotech sector is a vital economic engine in all 50 states, providing 2.1 million jobs and a $2.9 trillion impact on the
U.S. biotech is a major economic driver with a broad range, report says Read More »
The flu season is upon us and now is the time to get your flu vaccine. “About 5% to 20% of the U.S. population
CDC offers help in choosing a vaccine as flu season arrives Read More »
According to a new observational study, there is a possible association between exposure to aluminum adjuvants in childhood vaccines and the development of persistent
CDC advises no change for vaccines with aluminum adjuvants Read More »
